ADO (ASX) why ADO is a multi multi bagger

Originally posted by semi retired: ↑

Hi Captain , Investors must not realise EV1's design freeze is by the end of 2024 ? is by the end June this year and the scoping of EV2’s evaluations are expected to be completed in Q4 FY2024 with the evaluation expected to commence in early FY2025 is July-September this year , the latest announcement achieving 1,000 charge & discharge cycles with greater than 70% energy retention? how much greater than 70% ? this confirms the EV1 deal will go ahead and EVI want to keep it quiet from its competitors , can the Anteotech plant make enough ? they have confirmed the purchase of extra plant to scale up to 80,000 litre is very telling.

Announcements like the above should have more detail for investors to consider raising their investment , what WH/kg or mAh /g is achieved at the 400 cycles out of 1000 if 40% improvement in range @ 1000 cycles ? 400 cycles with such high energy retention should give at least 300,000 k drive range , I' ve never had a car with more than 150,000k,
good luck Anteo investors .

During the Quarter, the Company continued its work with a leading European car manufacturer or “EV1” on the optimisation of their anode for their next generation electric vehicle or EV batteries. This work has been progressing for a number of months, with initial testing by the customer in their laboratories confirming the results obtained by the Company that demonstrates an improvement in energy density and a reduction in costs of the anode. AnteoTech will continue its work with EV1 towards the common goal of improving the performance of the battery and making a reduction in the cost of the components of the anode.

The goal of this work is inclusion of Anteo X in EV1’s upcoming “design freeze” towards the end of 2024. Being included in the “design freeze” would see Anteo X incorporated into the batteries for EV1’s next generation vehicles. If the internal validation and testing processes being undertaken by EV1 is successful, the objective will then be for AnteoTech to secure commercial agreements for the sale of Anteo X for use in a broad range of the EV’s that the company produces.

The scoping of EV2’s evaluations are expected to be completed in Q4 FY2024 with the evaluation expected to commence in early FY2025. Based on the volumes of EVs that each company manufactured in 2023, and their forecast growth, this would equate to a significant volume of Anteo X providing a material revenue opportunity.

A further project is commencing with a leading Giga Factory that produces large volumes of EV batteries. The Factory has approached AnteoTech to assist in their transition to a higher silicon anode. The scoping and deliverables for this project are currently being finalised and it is expected that this will run in parallel with the EV projects.

Expand

and a big question many of us have is:

is anyone testing our 70% anode

is EV1 testing it in parallel with their own anode?

surely someone must be. 650 cycles at 80% would satisfy the requirements for many industries.
This anode would be comparable to a non silicon one doing over 4000 cycles before it hit 80%.
Sure, the cathode has now become a massive bottleneck but surely we don't need to prove any more than 500 cycles at 80% given the massive increase in energy density?

No.	Vol.	Price($)
4	1113604	2.1¢

No.

Vol.

Price($)

1113604

2.1¢

Price($)	Vol.	No.
2.2¢	180000	1

Price($)

Vol.

No.

2.2¢

180000

No.	Vol.	Price($)
4	1113604	0.021
10	1829550	0.020
10	3200136	0.019
11	1900665	0.018
4	194160	0.017

No.

Vol.

Price($)

1113604

0.021

1829550

0.020

3200136

0.019

1900665

0.018

194160

0.017

Price($)	Vol.	No.
0.022	180000	1
0.023	857853	5
0.024	1206228	2
0.025	195344	4
0.027	680612	2

Price($)

Vol.

No.

0.022

180000

0.023

857853

0.024

1206228

0.025

195344

0.027

680612

(20min delay)
Last 2.1¢		Change -0.001(4.55%)		Mkt cap ! $51.83M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.1¢	$14.69K	692.2K

why ADO is a multi multi bagger, page-132

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Patagonia looks to raise $2.15M for South American exploration and development

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

why ADO is a multi multi bagger, page-132

Top Stories

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Patagonia looks to raise $2.15M for South American exploration and development

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News